Related Experiment Video
Updated: May 25, 2026
08:03
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy
Abhimanyu Paraskar1, Shivani Soni, Bhaskar Roy
1Division of Biomedical Engineering, Department of Medicine, Brigham and Women's Hospital, Cambridge, MA 02139, USA.
Nanotechnology
|January 26, 2012
Summary
Researchers developed novel glucosamine-functionalized polyisobutylene maleic acid copolymer nanoparticles carrying platinum (DACH-platinum). These nanoparticles demonstrated enhanced anti-cancer efficacy and reduced toxicity compared to free oxaliplatin, showing preferential tumor accumulation.
Area of Science:
- Nanomedicine
- Polymer Chemistry
- Cancer Therapeutics
Background:
- Nanoscale drug delivery vehicles are crucial for cancer chemotherapy.
- Formulating platinum chemotherapeutics in nanoparticles presents challenges due to their properties.
- Few reports exist on oxaliplatin nanoparticles.
Purpose of the Study:
- To develop a novel nanoparticle formulation for platinum chemotherapeutics.
- To investigate the efficacy and biodistribution of the novel nanoparticle.
- To overcome challenges in formulating platinum drugs in nanocarriers.
Main Methods:
- Derivatization of polyisobutylene maleic acid copolymer with glucosamine.
- Chelation of trans-1,2-diaminocyclohexane (DACH) platinum (II).
- Self-assembly into nanoparticles, characterized by dynamic light scatter and electron microscopy.
- In vitro and in vivo efficacy studies, and biodistribution analysis using ICP-AAS.
Main Results:
- The PIMA-GA-DACH-platinum nanoparticle demonstrated higher activity than free oxaliplatin in vitro.
- In vivo studies showed superior tumor inhibition with reduced nephrotoxicity and body weight loss compared to oxaliplatin.
- ICP-AAS revealed preferential platinum accumulation in tumors and reduced accumulation in kidneys and liver.
Conclusions:
- Rational engineering of novel polymeric nanoparticles can enhance antitumor potency.
- The developed nanoparticle offers increased efficacy with reduced systemic toxicity compared to the parent drug.
- This strategy presents an exciting approach for synthesizing nanomedicines for cancer chemotherapy.
